Skip to main content

ADVERTISEMENT

solid cancer

Research in Review
07/25/2017
JCP Editors
Human epidermal growth factor receptor 2 (HER2)-targeted therapy results in different objective response rates (ORR) across cancer types based on mutation variants, according to recent research. ----- Related...
Human epidermal growth factor receptor 2 (HER2)-targeted therapy results in different objective response rates (ORR) across cancer types based on mutation variants, according to recent research. ----- Related...
Human...
07/25/2017
Journal of Clinical Pathways